The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.
Dimopoulos MA, Kastritis E, Michalis E, Tsatalas C, Michael M, Pouli A, Kartasis Z, Delimpasi S, Gika D, Zomas A, Roussou M, Konstantopoulos K, Parcharidou A, Zervas K, Terpos E; Greek Myeloma Study Group.
Dimopoulos MA, et al. Among authors: kastritis e.
Ann Oncol. 2012 Mar;23(3):722-729. doi: 10.1093/annonc/mdr276. Epub 2011 Jun 7.
Ann Oncol. 2012.
PMID: 21652580
Free article.